Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System

MLA

Chu, Yaya, et al. “Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System.” Transplantation and Cellular Therapy, vol. 29, no. 2, Number 2 Supplement 1, Feb. 2023, pp. S319–20. EBSCOhost, https://doi.org/10.1016/S2666-6367(23)00492-X.

APA

Chu, Y., Lamb, M., Maryamchik, E., Rigot, O., Ayello, J., Harrison, L., Mintzer, E., Shaw, R., Behbehani, G., Mardis, E., Miller, K., Rao Venkata, L. P., Chang, H., Lee, D. A., Rosenthal, E. Y., Kadauke, S., Bunin, N. J., Talano, J., Johnson, B. D., … Cairo, M. S. (2023). Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System. Transplantation and Cellular Therapy, 29(2, Number 2 Supplement 1), S319–S320. https://doi.org/10.1016/S2666-6367(23)00492-X

Chicago

Chu, Yaya, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Janet Ayello, Lauren Harrison, Elizabeth Mintzer, et al. 2023. “Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System.” Transplantation and Cellular Therapy 29 (2, Number 2 Supplement 1): S319–20. doi:10.1016/S2666-6367(23)00492-X.